Insulin-resistant brain state: The culprit in sporadic Alzheimer's disease?

Adamo, 1989, Insulin and insulin-like growth factor receptors in the nervous system, Mol. Neurobiol., 3, 71, 10.1007/BF02935589

Agrawal, 2009, A study of brain insulin receptors, AChE activity and oxidative stress in rat model of ICV STZ induced dementia, Neuropharmacology, 56, 779, 10.1016/j.neuropharm.2009.01.005

Arluison, 2004, Distribution and anatomical localization of the glucose transporter 2 (GLUT2) in the adult rat brain—an immunohistochemical study, J. Chem. Neuroanat., 28, 117, 10.1016/j.jchemneu.2004.05.009

Arluison, 2004, Immunocytochemical localization of the glucose transporter 2 (GLUT2) in the adult rat brain. II. Electron microscopic study, J. Chem. Neuroanat., 28, 137, 10.1016/j.jchemneu.2004.06.002

Azari, 1993, Early detection of Alzheimer's disease: a statistical approach using positron emission tomographic data, J. Cereb. Blood Flow Metab., 13, 438, 10.1038/jcbfm.1993.58

Banks, 2004, The source of cerebral insulin, Eur. J. Pharmacol., 490, 5, 10.1016/j.ejphar.2004.02.040

Baskin, 1999, Brain choline acetyltransferase and mental function in Alzheimer disease, Arch. Neurol., 56, 1121, 10.1001/archneur.56.9.1121

Bhat, 2010, Linking cardiometabolic disorders to sporadic Alzheimer's disease: a perspective on potential mechanisms and mediators, J. Neurochem., 115, 551, 10.1111/j.1471-4159.2010.06978.x

Blokland, 1993, Spatial learning deficit and reduced hippocampal ChAT activity in rats after an ICV injection of streptozotocin, Pharmacol. Biochem. Behav., 44, 491, 10.1016/0091-3057(93)90497-H

Blokland, 1994, Behavioral and biochemical effects of an ICV injection of streptozotocin in old Lewis rats, Pharmacol. Biochem. Behav., 47, 833, 10.1016/0091-3057(94)90284-4

Bosetti, 2002, Cytochrome c oxidase and mitochondrial F1F0-ATPase (ATP synthase) activities in platelets and brain from patients with Alzheimer's disease, Neurobiol. Aging, 23, 371, 10.1016/S0197-4580(01)00314-1

Bryant, 2002, Regulated transport of the glucose transporter GLUT4, Nat. Rev. Mol. Cell Biol., 3, 267, 10.1038/nrm782

Bubber, 2005, Mitochondrial abnormalities in Alzheimer brain: mechanistic implications, Ann. Neurol., 57, 695, 10.1002/ana.20474

Buee, 1994, Pathological alterations of the cerebral microvasculature in Alzheimer's disease and related dementing disorders, Acta Neuropathol., 87, 469, 10.1007/BF00294173

Burns, 2007, Peripheral insulin and brain structure in early Alzheimer disease, Neurology, 69, 1094, 10.1212/01.wnl.0000276952.91704.af

Cao, 2007, Intake of sucrose-sweetened water induces insulin resistance and exacerbates memory deficits and amyloidosis in a transgenic mouse model of Alzheimer disease, J. Biol. Chem., 282, 36275, 10.1074/jbc.M703561200

Cardoso, 2009, Insulin is a two-edged knife on the brain, J. Alzheimers Dis, 18, 483, 10.3233/JAD-2009-1155

Castellani, 2001, Active glycation in neurofibrillary pathology of Alzheimer disease: N(epsilon)-(carboxymethyl) lysine and hexitol-lysine, Free Radic. Biol. Med., 31, 175, 10.1016/S0891-5849(01)00570-6

Cheng, 2005, Tau is hyperphosphorylated in the insulin-like growth factor-I null brain, Endocrinology, 146, 5086, 10.1210/en.2005-0063

Cole, 2007, The role of insulin and neurotrophic factor signaling in brain aging and Alzheimer's disease, Exp. Gerontol., 42, 10, 10.1016/j.exger.2006.08.009

Craft, 1999, Enhancement of memory in Alzheimer disease with insulin and somatostatin, but not glucose, Arch. Gen. Psychiatry, 56, 1135, 10.1001/archpsyc.56.12.1135

Cross, 1995, Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B, Nature, 378, 785, 10.1038/378785a0

Czech, 1999, Signaling mechanisms that regulate glucose transport, J. Biol. Chem., 274, 1865, 10.1074/jbc.274.4.1865

Davis, 2006, Mitogen-activated protein kinase/extracellular regulated kinase signalling and memory stabilization: a review, Genes, Brain, Behavior, 5, 61, 10.1111/j.1601-183X.2006.00230.x

de la Monte, 2005, Review of insulin and insulin-like growth factor expression, signaling, and malfunction in the central nervous system: relevance to Alzheimer's disease, J. Alzheimers Dis., 7, 45, 10.3233/JAD-2005-7106

de la Monte, 2006, Molecular indices of oxidative stress and mitochondrial dysfunction occur early and often progress with severity of Alzheimer's disease, J. Alzheimers Dis., 9, 167, 10.3233/JAD-2006-9209

de la Monte, 2006, Therapeutic rescue of neurodegeneration in experimental type 3 diabetes: relevance to Alzheimer's disease, J. Alzheimers Dis., 10, 89, 10.3233/JAD-2006-10113

Deng, 2009, Dysregulation of insulin signaling, glucose transporters, O-GlcNAcylation, and phosphorylation of tau and neurofilaments in the brain: implication for Alzheimer's disease, Am. J. Pathol., 175, 2089, 10.2353/ajpath.2009.090157

Devaskar, 1994, Insulin gene expression and insulin synthesis in mammalian neuronal cells, J. Biol. Chem., 269, 8445, 10.1016/S0021-9258(17)37214-9

Doreulee, 2003, Cortico-striatal synaptic plasticity in endothelial nitric oxide synthase deficient mice, Brain Res., 964, 159, 10.1016/S0006-8993(02)04121-5

Droge, 2008, Aberrant insulin receptor signaling and amino acid homeostasis as a major cause of oxidative stress in aging, Antioxid. Redox Signal., 10, 661, 10.1089/ars.2007.1953

Dudek, 1997, Regulation of neuronal survival by the serine-threonine protein kinase Akt, Science, 275, 661, 10.1126/science.275.5300.661

Duelli, 1994, Intracerebroventricular injection of streptozotocin induces discrete local changes in cerebral glucose utilization in rats, Int. J. Dev. Neurosci., 12, 737, 10.1016/0736-5748(94)90053-1

Eckel-Mahan, 2008, Circadian oscillation of hippocampal MAPK activity and cAmp: implications for memory persistence, Nat. Neurosci., 11, 1074, 10.1038/nn.2174

Elsner, 2000, Relative importance of transport and alkylation for pancreatic beta-cell toxicity of streptozotocin, Diabetologia, 43, 1528, 10.1007/s001250051564

English, 1996, Activation of p42 mitogen-activated protein kinase in hippocampal long term potentiation, J. Biol. Chem., 271, 24329, 10.1074/jbc.271.40.24329

Erol, 2008, An integrated and unifying hypothesis for the metabolic basis of sporadic Alzheimer's disease, J. Alzheimers Dis., 13, 241, 10.3233/JAD-2008-13302

Frolich, 1998, Brain insulin and insulin receptors in aging and sporadic Alzheimer's disease, J. Neural Transm., 105, 423, 10.1007/s007020050068

Frolich, 1999, A disturbance in the neuronal insulin receptor signal transduction in sporadic Alzheimer's disease, Ann. N. Y. Acad. Sci., 893, 290, 10.1111/j.1749-6632.1999.tb07839.x

Games, 2006, Mice as models: transgenic approaches and Alzheimer's disease, J. Alzheimers Dis., 9, 133, 10.3233/JAD-2006-9S316

Gasparini, 2003, Potential roles of insulin and IGF-1 in Alzheimer's disease, Trends Neurosci., 26, 404, 10.1016/S0166-2236(03)00163-2

Gasparini, 2001, Stimulation of beta-amyloid precursor protein trafficking by insulin reduces intraneuronal beta-amyloid and requires mitogen-activated protein kinase signaling, J. Neurosci., 21, 2561, 10.1523/JNEUROSCI.21-08-02561.2001

Gimenez-Llort, 2007, Working memory deficits in transgenic rats overexpressing human adenosine A2A receptors in the brain, Neurobiol. Learn. Mem., 87, 42, 10.1016/j.nlm.2006.05.004

Goedert, 2006, A century of Alzheimer's disease, Science, 314, 777, 10.1126/science.1132814

Grieb, 2004, Expansion of the Golgi apparatus in rat cerebral cortex following intracerebroventricular injections of streptozotocin, Acta Neurobiol. Exp. (Wars), 64, 481, 10.55782/ane-2004-1531

Grunblatt, 2006, Gene expression alterations in brain areas of intracerebroventricular streptozotocin treated rat, J. Alzheimers Dis., 9, 261, 10.3233/JAD-2006-9305

Grunblatt, 2007, Brain insulin system dysfunction in streptozotocin intracerebroventricularly treated rats generates hyperphosphorylated tau protein, J. Neurochem., 101, 757, 10.1111/j.1471-4159.2006.04368.x

Hardy, 2002, The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics, Science, 297, 353, 10.1126/science.1072994

Havrankova, 1978, Insulin receptors are widely distributed in the central nervous system of the rat, Nature, 272, 827, 10.1038/272827a0

Hellweg, 1992, Nerve growth factor and choline acetyltransferase activity levels in the rat brain following experimental impairment of cerebral glucose and energy metabolism, J. Neurosci. Res., 31, 479, 10.1002/jnr.490310310

Henneberg, 1995, Desensitization of the neuronal insulin receptor: a new approach in the etiopathogenesis of late-onset sporadic dementia of the Alzheimer type (SDAT)?, Arch. Gerontol. Geriatr., 21, 63, 10.1016/0167-4943(95)00646-3

Hirai, 2001, Mitochondrial abnormalities in Alzheimer's disease, J. Neurosci., 21, 3017, 10.1523/JNEUROSCI.21-09-03017.2001

Ho, 2004, Diet-induced insulin resistance promotes amyloidosis in a transgenic mouse model of Alzheimer's disease, FASEB J., 18, 902, 10.1096/fj.03-0978fje

Hong, 1997, Insulin and insulin-like growth factor-1 regulate tau phosphorylation in cultured human neurons, J. Biol. Chem., 272, 19547, 10.1074/jbc.272.31.19547

Hoyer, 1998, Risk factors for Alzheimer's disease during aging. Impacts of glucose/energy metabolism, J. Neural Transm. Suppl., 54, 187, 10.1007/978-3-7091-7508-8_18

Hoyer, 2002, The brain insulin signal transduction system and sporadic (type II) Alzheimer disease: an update, J. Neural Transm., 109, 341, 10.1007/s007020200028

Hoyer, 2004, Causes and consequences of disturbances of cerebral glucose metabolism in sporadic Alzheimer disease: therapeutic implications, Adv. Exp. Med. Biol., 541, 135, 10.1007/978-1-4419-8969-7_8

Hoyer, 2004, Glucose metabolism and insulin receptor signal transduction in Alzheimer disease, Eur. J. Pharmacol., 490, 115, 10.1016/j.ejphar.2004.02.049

Hoyer, 1999, Inhibition of the neuronal insulin receptor causes Alzheimer-like disturbances in oxidative/energy brain metabolism and in behavior in adult rats, Ann. N. Y. Acad. Sci., 893, 301, 10.1111/j.1749-6632.1999.tb07842.x

Hoyer, 1989, Cerebral excess release of neurotransmitter amino acids subsequent to reduced cerebral glucose metabolism in early-onset dementia of Alzheimer type, J. Neural Transm., 75, 227, 10.1007/BF01258634

Huang, 2003, Inhibition of alpha-ketoglutarate dehydrogenase complex promotes cytochrome c release from mitochondria, caspase-3 activation, and necrotic cell death, J. Neurosci. Res., 74, 309, 10.1002/jnr.10756

Ishiguro, 1993, Glycogen synthase kinase 3 beta is identical to tau protein kinase I generating several epitopes of paired helical filaments, FEBS Lett., 325, 167, 10.1016/0014-5793(93)81066-9

Ishrat, 2006, Coenzyme Q10 modulates cognitive impairment against intracerebroventricular injection of streptozotocin in rats, Behav. Brain Res., 171, 9, 10.1016/j.bbr.2006.03.009

Johnston, 2003, Molecular mechanisms of insulin receptor substrate protein-mediated modulation of insulin signalling, FEBS Lett., 546, 32, 10.1016/S0014-5793(03)00438-1

Joseph, 2001, Copernicus revisited: amyloid beta in Alzheimer's disease, Neurobiol. Aging, 22, 131, 10.1016/S0197-4580(00)00211-6

Kahn, 1988, The insulin receptor and the molecular mechanism of insulin action, J. Clin. Invest., 82, 1151, 10.1172/JCI113711

Katakam, 2009, Cerebrovascular responses to insulin in rats, J. Cereb. Blood Flow Metab., 29, 1955, 10.1038/jcbfm.2009.177

Katakam, 2009, Impaired mitochondria-dependent vasodilation in cerebral arteries of Zucker obese rats with insulin resistance, Am. J. Physiol. Regul. Integr. Comp. Physiol., 296, R289, 10.1152/ajpregu.90656.2008

Kidd, 1964, Alzheimer's disease—an electron microscopical study, Brain, 87, 307, 10.1093/brain/87.2.307

Kish, 1992, Brain cytochrome oxidase in Alzheimer's disease, J. Neurochem., 59, 776, 10.1111/j.1471-4159.1992.tb09439.x

Lannert, 1998, Intracerebroventricular administration of streptozotocin causes long-term diminutions in learning and memory abilities and in cerebral energy metabolism in adult rats, Behav. Neurosci., 112, 1199, 10.1037/0735-7044.112.5.1199

Laske, 2006, Stage-dependent BDNF serum concentrations in Alzheimer's disease, J. Neural Transm., 113, 1217, 10.1007/s00702-005-0397-y

Lee, 2005, Decreased levels of BDNF protein in Alzheimer temporal cortex are independent of BDNF polymorphisms, Exp. Neurol., 194, 91, 10.1016/j.expneurol.2005.01.026

Leissring, 2003, Enhanced proteolysis of beta-amyloid in APP transgenic mice prevents plaque formation, secondary pathology, and premature death, Neuron, 40, 1087, 10.1016/S0896-6273(03)00787-6

Lester-Coll, 2006, Intracerebral streptozotocin model of type 3 diabetes: relevance to sporadic Alzheimer's disease, J. Alzheimers Dis., 9, 13, 10.3233/JAD-2006-9102

Li, 2007, Common pathological processes in Alzheimer disease and type 2 diabetes: a review, Brain Res. Rev., 56, 384, 10.1016/j.brainresrev.2007.09.001

Liu, 2008, Decreased glucose transporters correlate to abnormal hyperphosphorylation of tau in Alzheimer disease, FEBS Lett., 582, 359, 10.1016/j.febslet.2007.12.035

Lizcano, 2002, The insulin signalling pathway, Curr. Biol., 12, R236, 10.1016/S0960-9822(02)00777-7

Lopez-Lopez, 2007, Disturbed cross talk between insulin-like growth factor I and AMP-activated protein kinase as a possible cause of vascular dysfunction in the amyloid precursor protein/presenilin 2 mouse model of Alzheimer's disease, J. Neurosci., 27, 824, 10.1523/JNEUROSCI.4345-06.2007

Lucas, 2001, Decreased nuclear beta-catenin, tau hyperphosphorylation and neurodegeneration in GSK-3beta conditional transgenic mice, EMBO J., 20, 27, 10.1093/emboj/20.1.27

Luse, 1964, The ultrastructure of senile plaques, Am. J. Pathol., 44, 553

Man, 2000, Regulation of AMPA receptor-mediated synaptic transmission by clathrin-dependent receptor internalization, Neuron, 25, 649, 10.1016/S0896-6273(00)81067-3

Margolis, 1967, Insulin in the cerebrospinal fluid, Nature, 215, 1375, 10.1038/2151375a0

Mattson, 2001, Perturbed endoplasmic reticulum function, synaptic apoptosis and the pathogenesis of Alzheimer's disease, Biochem. Soc. Symp., 151, 10.1042/bss0670151

McEwen, 2004, Glucose transporter expression in the central nervous system: relationship to synaptic function, Eur. J. Pharmacol., 490, 13, 10.1016/j.ejphar.2004.02.041

McGeer, 1984, Aging, Alzheimer's disease, and the cholinergic system of the basal forebrain, Neurology, 34, 741, 10.1212/WNL.34.6.741

Moloney, 2010, Defects in IGF-1 receptor, insulin receptor and IRS-1/2 in Alzheimer's disease indicate possible resistance to IGF-1 and insulin signalling, Neurobiol. Aging, 31, 224, 10.1016/j.neurobiolaging.2008.04.002

Montagnani, 2001, Insulin-stimulated activation of eNOS is independent of Ca2+ but requires phosphorylation by Akt at Ser(1179), J. Biol. Chem., 276, 30392, 10.1074/jbc.M103702200

Moreira, 2006, Brain and brawn: parallels in oxidative strength, Neurology, 66, S97, 10.1212/01.wnl.0000192307.15103.83

Moreira, 2007, Lipoic acid and N-acetyl cysteine decrease mitochondrial-related oxidative stress in Alzheimer disease patient fibroblasts, J. Alzheimers Dis., 12, 195, 10.3233/JAD-2007-12210

Moreira, 2007, Alzheimer's disease: a lesson from mitochondrial dysfunction, Antioxid. Redox Signal., 9, 1621, 10.1089/ars.2007.1703

Moreira, 2007, Brain mitochondrial dysfunction as a link between Alzheimer's disease and diabetes, J. Neurol. Sci., 257, 206, 10.1016/j.jns.2007.01.017

Moreira, 2009, An integrative view of the role of oxidative stress, mitochondria and insulin in Alzheimer's disease, J. Alzheimers Dis., 16, 741, 10.3233/JAD-2009-0972

Nitsch, 1991, Local action of the diabetogenic drug, streptozotocin, on glucose and energy metabolism in rat brain cortex, Neurosci. Lett., 128, 199, 10.1016/0304-3940(91)90260-Z

Nunomura, 1999, RNA oxidation is a prominent feature of vulnerable neurons in Alzheimer's disease, J. Neurosci., 19, 1959, 10.1523/JNEUROSCI.19-06-01959.1999

Nunomura, 2001, Oxidative damage is the earliest event in Alzheimer disease, J. Neuropathol. Exp. Neurol., 60, 759, 10.1093/jnen/60.8.759

Park, 2001, Cognitive effects of insulin in the central nervous system, Neurosci. Biobehav. Rev., 25, 311, 10.1016/S0149-7634(01)00016-1

Parker, 1994, Reduced platelet cytochrome c oxidase activity in Alzheimer's disease, Neurology, 44, 1086, 10.1212/WNL.44.6.1086

Pathan, 2006, Chronic administration of pioglitazone attenuates intracerebroventricular streptozotocin induced-memory impairment in rats, Life Sci., 79, 2209, 10.1016/j.lfs.2006.07.018

Paz, 1996, Interaction between the insulin receptor and its downstream effectors. Use of individually expressed receptor domains for structure/function analysis, J. Biol. Chem., 271, 6998, 10.1074/jbc.271.12.6998

Pei, 2003, Role of protein kinase B in Alzheimer's neurofibrillary pathology, Acta Neuropathol, 105, 381, 10.1007/s00401-002-0657-y

Phiel, 2003, GSK-3alpha regulates production of Alzheimer's disease amyloid-beta peptides, Nature, 423, 435, 10.1038/nature01640

Plaschke, 1993, Action of the diabetogenic drug streptozotocin on glycolytic and glycogenolytic metabolism in adult rat brain cortex and hippocampus, Int. J. Dev. Neurosci., 11, 477, 10.1016/0736-5748(93)90021-5

Plaschke, 2010, Insulin-resistant brain state after intracerebroventricular streptozotocin injection exacerbates Alzheimer-like changes in Tg2576 AbetaPP-overexpressing mice, J. Alzheimers Dis., 19, 691, 10.3233/JAD-2010-1270

Prickaerts, 1999, Cognitive performance and biochemical markers in septum, hippocampus and striatum of rats after an i.c.v. injection of streptozotocin: a correlation analysis, Behav. Brain Res., 102, 73, 10.1016/S0166-4328(98)00158-2

Prickaerts, 2000, Nitric oxide synthase does not mediate neurotoxicity after an i.c.v. injection of streptozotocin in the rat, J. Neural Transm., 107, 745, 10.1007/s007020070056

Qiu, 1998, Insulin-degrading enzyme regulates extracellular levels of amyloid beta-protein by degradation, J. Biol. Chem., 273, 32730, 10.1074/jbc.273.49.32730

Querfurth, 2010, Alzheimer's disease, N. Engl. J. Med., 362, 329, 10.1056/NEJMra0909142

Rapoport, 2003, Coupled reductions in brain oxidative phosphorylation and synaptic function can be quantified and staged in the course of Alzheimer disease, Neurotox. Res., 5, 385, 10.1007/BF03033167

Rivera, 2005, Insulin and insulin-like growth factor expression and function deteriorate with progression of Alzheimer's disease: link to brain reductions in acetylcholine, J. Alzheimers Dis., 8, 247, 10.3233/JAD-2005-8304

Rocchi, 2003, Causative and susceptibility genes for Alzheimer's disease: a review, Brain Res. Bull., 61, 1, 10.1016/S0361-9230(03)00067-4

Rocchi, 2009, The role of vascular factors in late-onset sporadic Alzheimer's disease. Genetic and molecular aspects, Curr. Alzheimer Res., 6, 224, 10.2174/156720509788486644

Salkovic-Petrisic, 2007, Central insulin resistance as a trigger for sporadic Alzheimer-like pathology: an experimental approach, J. Neural Transm. Suppl., 217, 10.1007/978-3-211-73574-9_28

Salkovic-Petrisic, 2006, Alzheimer-like changes in protein kinase B and glycogen synthase kinase-3 in rat frontal cortex and hippocampus after damage to the insulin signalling pathway, J. Neurochem., 96, 1005, 10.1111/j.1471-4159.2005.03637.x

Saltiel, 2002, Insulin signaling pathways in time and space, Trends Cell Biol., 12, 65, 10.1016/S0962-8924(01)02207-3

Santos, 1999, Stimulation of immunoreactive insulin release by glucose in rat brain synaptosomes, Neurochem. Res., 24, 33, 10.1023/A:1020971812098

Schechter, 2001, Neuronal synthesized insulin roles on neural differentiation within fetal rat neuron cell cultures, Brain Res. Dev. Brain Res., 127, 41, 10.1016/S0165-3806(01)00110-9

Schechter, 1992, Developmental regulation of insulin in the mammalian central nervous system, Brain Res., 582, 27, 10.1016/0006-8993(92)90313-X

Schechter, 1996, Preproinsulin I and II mRNAs and insulin electron microscopic immunoreaction are present within the rat fetal nervous system, Brain Res., 736, 16, 10.1016/0006-8993(96)00664-6

Scheepers, 2004, The glucose transporter families SGLT and GLUT: molecular basis of normal and aberrant function, JPEN. J. Parenter. Enteral Nutr., 28, 364, 10.1177/0148607104028005364

Schubert, 2004, Role for neuronal insulin resistance in neurodegenerative diseases, Proc. Natl. Acad. Sci. U.S.A., 101, 3100, 10.1073/pnas.0308724101

Selkoe, 2001, Alzheimer's disease results from the cerebral accumulation and cytotoxicity of amyloid beta-protein, J. Alzheimers Dis., 3, 75, 10.3233/JAD-2001-3111

Sharma, 2001, Intracerebroventricular injection of streptozotocin in rats produces both oxidative stress in the brain and cognitive impairment, Life Sci., 68, 1021, 10.1016/S0024-3205(00)01005-5

Sharma, 2002, Chronic treatment with trans resveratrol prevents intracerebroventricular streptozotocin induced cognitive impairment and oxidative stress in rats, Life Sci., 71, 2489, 10.1016/S0024-3205(02)02083-0

Shoham, 2003, Intracerebroventricular injection of streptozotocin causes neurotoxicity to myelin that contributes to spatial memory deficits in rats, Exp. Neurol., 184, 1043, 10.1016/j.expneurol.2003.08.015

Shoham, 2007, Ladostigil prevents gliosis, oxidative-nitrative stress and memory deficits induced by intracerebroventricular injection of streptozotocin in rats, Neuropharmacology, 52, 836, 10.1016/j.neuropharm.2006.10.005

Silverman, 2001, Positron emission tomography in evaluation of dementia: regional brain metabolism and long-term outcome, JAMA, 286, 2120, 10.1001/jama.286.17.2120

Sims, 1983, Presynaptic cholinergic dysfunction in patients with dementia, J. Neurochem., 40, 503, 10.1111/j.1471-4159.1983.tb11311.x

Skoog, 2000, Vascular aspects in Alzheimer's disease, J. Neural Transm. Suppl., 59, 37

Small, 1996, Early detection of Alzheimer's disease by combining apolipoprotein E and neuroimaging, Ann. N. Y. Acad. Sci., 802, 70, 10.1111/j.1749-6632.1996.tb32600.x

Smith, 1997, Widespread peroxynitrite-mediated damage in Alzheimer's disease, J. Neurosci., 17, 2653, 10.1523/JNEUROSCI.17-08-02653.1997

Solano, 2000, Insulin regulates soluble amyloid precursor protein release via phosphatidyl inositol 3 kinase-dependent pathway, FASEB J., 14, 1015, 10.1096/fasebj.14.7.1015

Sonkusare, 2005, Effect of donepezil and lercanidipine on memory impairment induced by intracerebroventricular streptozotocin in rats, Life Sci., 77, 1, 10.1016/j.lfs.2004.10.036

Steen, 2005, Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease—is this type 3 diabetes?, J. Alzheimers Dis., 7, 63, 10.3233/JAD-2005-7107

Straface, 2005, Oxidative imbalance and cathepsin D changes as peripheral blood biomarkers of Alzheimer disease: a pilot study, FEBS Lett., 579, 2759, 10.1016/j.febslet.2005.03.094

Szkudelski, 2001, The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas, Physiol. Res., 50, 537

Takeda, 2010, Diabetes-accelerated memory dysfunction via cerebrovascular inflammation and Abeta deposition in an Alzheimer mouse model with diabetes, Proc. Natl. Acad. Sci. U.S.A., 107, 7036, 10.1073/pnas.1000645107

Tarkowski, 2002, Increased intrathecal levels of the angiogenic factors VEGF and TGF-beta in Alzheimer's disease and vascular dementia, Neurobiol. Aging, 23, 237, 10.1016/S0197-4580(01)00285-8

Terry, 1964, Ultrastructural studies in Alzheimer's presenile dementia, Am. J. Pathol., 44, 269

Terwel, 1995, Brain enzyme activities after intracerebroventricular injection of streptozotocin in rats receiving acetyl-L-carnitine, Eur. J. Pharmacol., 287, 65, 10.1016/0014-2999(95)00475-4

Tota, 2010, Protective effect of quercetin against intracerebral streptozotocin induced reduction in cerebral blood flow and impairment of memory in mice, Behav. Brain Res., 209, 73, 10.1016/j.bbr.2010.01.017

Tretter, 2000, Inhibition of Krebs cycle enzymes by hydrogen peroxide: a key role of [alpha]-ketoglutarate dehydrogenase in limiting NADH production under oxidative stress, J. Neurosci., 20, 8972, 10.1523/JNEUROSCI.20-24-08972.2000

Unger, 1989, Distribution of insulin receptor-like immunoreactivity in the rat forebrain, Neuroscience, 31, 143, 10.1016/0306-4522(89)90036-5

Valla, 2006, Impaired platelet mitochondrial activity in Alzheimer's disease and mild cognitive impairment, Mitochondrion, 6, 323, 10.1016/j.mito.2006.10.004

van der Heide, 2006, Insulin signaling in the central nervous system: learning to survive, Prog. Neurobiol., 79, 205, 10.1016/j.pneurobio.2006.06.003

Vannucci, 1997, Glucose transporter proteins in brain: delivery of glucose to neurons and glia, Glia, 21, 2, 10.1002/(SICI)1098-1136(199709)21:1<2::AID-GLIA2>3.0.CO;2-C

Vekrellis, 2000, Neurons regulate extracellular levels of amyloid beta-protein via proteolysis by insulin-degrading enzyme, J. Neurosci., 20, 1657, 10.1523/JNEUROSCI.20-05-01657.2000

Wan, 1997, Recruitment of functional GABA(A) receptors to postsynaptic domains by insulin, Nature, 388, 686, 10.1038/41792

Wang, 2007, Amyolid precursor protein mediates presynaptic localization and activity of the high-affinity choline transporter, Proc. Natl. Acad. Sci. U.S.A., 104, 14140, 10.1073/pnas.0704070104

Watson, 2004, Modulation of memory by insulin and glucose: neuropsychological observations in Alzheimer's disease, Eur. J. Pharmacol., 490, 97, 10.1016/j.ejphar.2004.02.048

Watson, 2003, Insulin increases CSF Abeta42 levels in normal older adults, Neurology, 60, 1899, 10.1212/01.WNL.0000065916.25128.25

Weinstock, 2004, Rat models of dementia based on reductions in regional glucose metabolism, cerebral blood flow and cytochrome oxidase activity, J. Neural Transm., 111, 347, 10.1007/s00702-003-0058-y

White, 1994, The insulin signaling system, J. Biol. Chem., 269, 1, 10.1016/S0021-9258(17)42297-6

Whitehouse, 1982, Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain, Science, 215, 1237, 10.1126/science.7058341

Wozniak, 1993, The cellular and physiological actions of insulin in the central nervous system, Neurochem. Int., 22, 1, 10.1016/0197-0186(93)90062-A

Xia, 1995, Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis, Science, 270, 1326, 10.1126/science.270.5240.1326

Young, 1986, Periventricular hypothalamic cells in the rat brain contain insulin mRNA, Neuropeptides, 8, 93, 10.1016/0143-4179(86)90035-1

Yu, 1998, The 45 kDa form of glucose transporter 1 (GLUT1) is localized in oligodendrocyte and astrocyte but not in microglia in the rat brain, Brain Res., 797, 65, 10.1016/S0006-8993(98)00372-2

Zhao, 2004, Insulin and the insulin receptor in experimental models of learning and memory, Eur. J. Pharmacol., 490, 71, 10.1016/j.ejphar.2004.02.045